First ultra-short-acting beta-adrenergic blocking agent: its effect on size and segmental wall dynamics of reperfused myocardial infarcts in dogs.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D000818:Animals; D001345:Autoradiography / Q000379:methods; D003326:Coronary Circulation / Q000187:drug effects; D004285:Dogs; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D007263:Infusions, Parenteral; D009200:Myocardial Contraction / Q000187:drug effects*; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000503:physiopathology; D009206:Myocardium / Q000032:analysis; D011412:Propanolamines / Q000008:administration & dosage*
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; C036604:esmolol